Maris-Tech Ltd.

MTEK·NasdaqCM·Technology
Compare
0.2600−0.0736 (−22.06%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.3336
Open0.3490
Day range0.20950.3490
52-week range0.20952.8200
Off day high−25.50%
Off 52-week high−90.78%
Volume503.46K
Avg. volume (3M)889.84K
Market cap2.75M
EPS (TTM)-0.6600
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.84
Shares outstanding10.56M
Short interest5.47% of float
Earnings date—
Analyst target—
Profit margin−215.27%

Against its peers

Compare in full ›
MTEK UNIBAP.ST DAKT 1478.HK 3652.T 2374.TW
Market cap 2.75M 715.69M 977.24M 5.45B 7.37B 19.26B
P/E (TTM) — — 20.7 3.3 — 17.2
Forward P/E — — 12.7 5.2 28.5 -100.0
Price/book 0.9 5.4 3.1 0.7 2.3 2.2
Dividend yield — — — 12.53% — 3.34%
1-year change −81.02% +34.54% −1.27% −64.28% +14.18% −26.78%
Today −22.06% +2.48% +4.26% +3.99% −7.98% −4.36%

The closest companies by business and industry (Electronic Components). Prices may be delayed up to 20 min.

Latest news

All MTEK news ›
Stock Titan·Positive

Maris-Tech plans 360° vehicle vision demos at AUSA

Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01 Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict…

Stock Titan·Positive

Maris-Tech receives armored vehicle pilot order

Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01 Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict…

Stock Titan·Positive

Maris Tech stake report lists 20.64% and 1.66%

Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01 Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict…

Stock Titan··2 outletsPositive

Maris-Tech Introduces Uranus-Drones-V2, a Video and AI Processing Platform for Drone Applications

The company expects the platform to generate orders from both existing and new drone manufacturers. Maris-Tech (MTEK) launched Uranus-Drones-V2, a video and artificial intelligence processing platform designed for integration into unmanned…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

7mentions in 30 days
6with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance